These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10416916)

  • 41. Physiologic assessment of milrinone therapy in severe heart failure patients.
    Dubois-Randé JL; Duval-Moulin AM; Saal JP; Merlet P; Lellouche D; Deleuze P; Dupouy P; Brun P; Loisance D; Castaigne A
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):941-8. PubMed ID: 1714019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short-term assessment of left ventricular function, coronary hemodynamics, and catecholamine balance in severe congestive heart failure after a single oral dose of milrinone.
    Piscione F; Jaski BE; Serruys PW
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):258-69. PubMed ID: 2452918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy.
    Biddle TL; Benotti JR; Creager MA; Faxon DP; Firth BG; Fitzpatrick PG; Konstam MA; Krebs C; Walton L; Kershner RP
    Am J Cardiol; 1987 Jun; 59(15):1345-50. PubMed ID: 3591689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study.
    Lechner E; Hofer A; Leitner-Peneder G; Freynschlag R; Mair R; Weinzettel R; Rehak P; Gombotz H
    Pediatr Crit Care Med; 2012 Sep; 13(5):542-8. PubMed ID: 22622649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of oral milrinone on end-systolic relations in patients with severe congestive heart failure.
    Miller WP; Ark CR; Wiederholt P
    Am J Cardiol; 1987 Oct; 60(10):842-6. PubMed ID: 3661398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.
    Monrad ES; Baim DS; Smith HS; Lanoue A; Brauwald E; Grossman W
    Circulation; 1985 May; 71(5):972-9. PubMed ID: 3986984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effective milrinone therapy to a Duchenne muscular dystrophy patient with advanced congestive heart failure].
    Matsumura T; Saito T; Miyai I; Nozaki S; Kang J
    Rinsho Shinkeigaku; 1999 Jun; 39(6):643-8. PubMed ID: 10502990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Milrinone in heart failure. Effects on exercise haemodynamics during short term treatment.
    Timmis AD; Smyth P; Jewitt DE
    Br Heart J; 1985 Jul; 54(1):42-7. PubMed ID: 4015915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of milrinone in the management of congestive heart failure.
    Hilleman DE; Forbes WP
    DICP; 1989 May; 23(5):357-62. PubMed ID: 2658377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of a twenty-four-hour milrinone infusion in patients with severe heart failure and cardiogenic shock as a function of the hemodynamic initial condition.
    Klocke RK; Mager G; Kux A; Höpp HW; Hilger HH
    Am Heart J; 1991 Jun; 121(6 Pt 2):1965-73. PubMed ID: 2035428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT.
    Thackray S; Witte K; Clark AL; Cleland JG
    Eur J Heart Fail; 2000 Jun; 2(2):209-12. PubMed ID: 10856736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
    Mishra A; Kumar B; Dutta V; Arya VK; Mishra AK
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):639-46. PubMed ID: 27321790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure.
    Benotti JR; Lesko LJ; McCue JE; Alpert JS
    Am J Cardiol; 1985 Oct; 56(10):685-9. PubMed ID: 4050707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardioprotective and functional effects of levosimendan and milrinone in mice with cecal ligation and puncture-induced sepsis.
    Yamashita S; Suzuki T; Iguchi K; Sakamoto T; Tomita K; Yokoo H; Sakai M; Misawa H; Hattori K; Nagata T; Watanabe Y; Matsuda N; Yoshimura N; Hattori Y
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Sep; 391(9):1021-1032. PubMed ID: 29922941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hemodynamic study of intravenous milrinone in 26 patients with NYHA class III or IV cardiac failure].
    Boesch C; Dubois-Rande JL; Pochmalicki G; Lellouche D; Teiger E; Saal JP; Cachin JC; Mallo C; Castaigne A; Jan F
    Ann Cardiol Angeiol (Paris); 1992 Nov; 41(9):509-12. PubMed ID: 1298193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myocardial and vascular actions of milrinone.
    Colucci WS
    Eur Heart J; 1989 Aug; 10 Suppl C():32-8. PubMed ID: 2680495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hemodynamic effects of milrinone on patients with chronic congestive heart failure: a multicenter study. Cooperative Group for Phase II Clinical Trial of Milrinone].
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):599-602. PubMed ID: 8697925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Milrinone. A preliminary review of its pharmacological properties and therapeutic use.
    Young RA; Ward A
    Drugs; 1988 Aug; 36(2):158-92. PubMed ID: 3053125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.